🦊/Companies

Tabula

8 known investors

Find your way into Tabula

Tabula Bio uses machine learning to design in-context DNA algorithms that can outpace microbial evolution and treat infectious disease, positioning itself as an alternative to traditional antibiotic and drug development. The company applies AI to design new DNA faster than pathogens can evolve resistance, and states it is already treating patients.

Investors · 8

In the news

Frequently asked questions

What does Tabula do?
Tabula Bio uses machine learning to design in-context DNA algorithms that can outpace microbial evolution and treat infectious disease, positioning itself as an alternative to traditional antibiotic and drug development. The company applies AI to design new DNA faster than pathogens can evolve resistance, and states it is already treating patients.
Who are Tabula's investors?
Tabula's investors include Maven Ventures, Zypsy Capital, Balderton Capital, Benchmark, Crosslink Capital, Dag Ventures, Greylock Partners, New Enterprise Associates (NEA).